The Department of Health and Human Services, Food and Drug Administration awarded a $24,519,103.59 Delivery Order contract to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract supports the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS, which involves providing data sources and conducting surveillance of biological drug safety. The contract is a Time and Materials type with a period of performance...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...
This is a $8,614,570.87 delivery order contract awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc., a non-profit healthcare organization. The contract supports the FDA's Sentinel System for post-market medical product safety surveillance, including developing and maintaining the Sentinel Innovation Center and conducting comprehensive data analytics projects. The contract is not set-aside. Harvard Pilgrim Health Care Inc. has established itself as a critical...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle. The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work...
This is a federal contract award from the National Institutes of Health (NIH) Clinical Center to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $77,262.73, is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices. The award is a delivery order contract with a firm-fixed price pricing type, and it has an ultimate completion date of August 17, 2020. This...
This is a federal contract award issued by the National Institutes of Health (NIH) Clinical Center to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $98,365.27, is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, with a...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,596 delivery order contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a...
This federal contract award, valued at $97,874.92, was issued by the Office of the Chief Operating Officer, a civilian agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. The contract covers the delivery of a broad range of pharmaceutical products and medical supplies,...
This is a federal contract award issued by the National Institutes of Health (NIH) Clinical Center to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $89,527.03, is a Firm Fixed Price Delivery Order that does not have a set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support...
This is a $83,607.88 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Office of the Chief Operating Officer of the Department of Health and Human Services. The contract is for the provision of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support federal healthcare...